Molecular mechanism of cardiac hypertrophy and development

I Komuro1

  • 1Department of Cardiovascular Medicine, University of Tokyo Graduate School of Medicine, Japan. komuro-tky@umin.ac.jp

Insights

Mechanical stress causes cardiac hypertrophy, a key factor in heart failure. Researchers developed an in-vitro model to study this process, identifying key signaling pathways and genes like Csx involved in cardiac development and disease.

Area of Science:

  • Cardiology
  • Molecular Biology
  • Developmental Biology

Background:

  • Congestive heart failure is a significant clinical challenge.
  • Understanding cardiac hypertrophy mechanisms is crucial for heart failure research.
  • Mechanical stress is a primary driver of cardiac hypertrophy.

Purpose of the Study:

  • To investigate the signaling pathways linking mechanical stress to cardiac hypertrophy.
  • To identify key genes and molecular mechanisms involved in cardiac development and differentiation.
  • To explore potential therapeutic strategies for heart failure.

Main Methods:

  • Developed an in-vitro device to apply mechanical stress to neonatal rat cardiac myocytes.
  • Analyzed hypertrophic responses including protein kinase activation, gene expression, and protein synthesis.
  • Isolated and studied the role of the cardiac homeobox-containing gene Csx in cardiac development.

Main Results:

  • Mechanical stretching of cardiac myocytes induced hypertrophic responses.
  • Vasoactive peptides (angiotensin II, endothelin-1) were upregulated and critical for hypertrophy.
  • The gene Csx is essential for cardiac development; its disruption leads to embryonic lethality.
  • Csx, with GATA4, induces cardiomyocyte differentiation and upregulates cardiac genes.

Conclusions:

  • Mechanical stress initiates signaling cascades leading to cardiac hypertrophy.
  • Vasoactive peptides play a critical role in mediating stress-induced cardiac hypertrophy.
  • The Csx gene is a vital regulator of cardiac development and differentiation.
  • Understanding Csx function is important for congenital heart disease research and potential therapies.

Related Concept Videos

Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Cellular Adaptation II: Hypertrophy01:26

Cellular Adaptation II: Hypertrophy

Hypertrophy is the increase in the size of individual cells, resulting in the enlargement of a tissue or organ. Unlike hyperplasia, which involves an increase in cell number, hypertrophy is characterized by an increase in cell volume. This process often occurs in response to higher functional demand or hormonal stimulation, leading to the production of more structural proteins and organelles, thereby enhancing the cells' work capacity.There are two primary types of hypertrophy: physiological...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
Structure of Cardiac Muscles01:13

Structure of Cardiac Muscles

Cardiac muscle, or myocardium, is a specialized type of muscle found exclusively in the heart. Its unique structural and functional characteristics enable the heart to perform its vital role of pumping blood throughout the body continuously and rhythmically. The cardiac muscle cells, or cardiomyocytes, possess an endomysium and perimysium but do not have an epimysium.
Compared to skeletal muscles, cardiac muscle cells are small and mostly have a single nucleus. Additionally, they are usually...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...